How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 901–1,000 of 1,008
Karami, F., Jamaati, H., Coleman‐Fuller, N., Zeini, M. S., Hayes, A. W., Gholami, M., Salehirad, M., Darabi, M., & Motaghinejad, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00469-1 · Cited by 21
Wang, L., Ding, Y., Wu, Y.-Q., Zhao, C., Wu, J. C., Wang, W.-J., & Meng, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115608 · Cited by 23
Wang, Z., Xiong, L., Wan, W., Duan, L., Bai, X., & Zu, H. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00032 · Cited by 22
“In addition, activated microglia secrete a wide range of cytokines and other proinflammatory factors, which contributes to neurodegeneration and exacerbate inflammatory reactions by recruiting and stimulating astrocytes (Rubio-Perez and Morillas-Ruiz, 2012; Ransohoff, 2016).”
BackgroundEmerging roles of protein kinases in microglia-mediated neuroinflammation
Lee, S. H., & Suk, K. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.137 · Cited by 24
Song, L., Yan, Y., Marzano, M., & Li, Y. (2019) · Cells · doi:10.3390/cells8040299 · Cited by 22
“While macrophage/microglia polarization states have been defined as classical activation (M1), alternative activation (M2a), type II alternative activation (M2b) or acquired deactivation (M2c) [107], this strict and simplistic classification is not considered to adequately describe the complex physiology of microglial…”
BackgroundMeng, C., Gao, J. Q., Ma, Q., Sun, Q., & Qiao, T. (2020) · Neurological Research · doi:10.1080/01616412.2020.1834290 · Cited by 22
Cellular uptake and anti-inflammatory effects of palm oil-derived delta (δ)-tocotrienol in microglia
Tan, S. W., Ali, D. A. I., Khaza’ai, H., Wong, J. W., & Vidyadaran, S. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104200 · Cited by 23
PET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 21
Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson’s Disease
Policastro, G., Brunelli, M., Tinazzi, M., Chiamulera, C., Emerich, D. F., & Paolone, G. (2020) · Neural Plasticity · doi:10.1155/2020/8814028 · Cited by 21
Selenium Effects on Oxidative Stress-Induced Calcium Signaling Pathways in Parkinson’s Disease
Salaramoli, S., Joshaghani, H., & Hashemy, S. I. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01031-1 · Cited by 22
Bivona, G., Iemmolo, M., Piccoli, T., Agnello, L., Sasso, B. L., Ciaccio, M., & Ghersi, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195498 · Cited by 22
Valencia, J., Ferreira, M. S., Merino-Torres, J. F., Marcilla, A., & Soriano, J. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911508 · Cited by 24
“This glial reaction is thought to happen due to neuronal death or dysfunction [67,68].”
BackgroundSharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 21
“These common neuroinflammatory aspects, in both animal and human models of PD, are characterized by reactive astrocytes and activated microglia, involvement of the innate and adaptive immune system, enhanced expression of pro-inflammatory chemoand cytokines, and increased concentrations of reactive oxygen and nitrogen…”
BackgroundThe Role of Microglial Depletion Approaches in Pathological Condition of CNS
Tahmasebi, F., & Barati, S. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01326-8 · Cited by 22
“These events showed that microglia play a complex role in CNS homeostasis and disease states (Ransohoff 2016).”
BackgroundRavenhill, S. M., Evans, A. H., & Crewther, S. G. (2023) · Antioxidants · doi:10.3390/antiox12051117 · Cited by 25
Huan, P.-F., Sun, X., He, Z.-Q., Yang, S., Wang, L., Xie, H., Wang, L., & He, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155019 · Cited by 23
Jia, Y., Li, J., Wang, Y., Ma, Y., Chen, L., Zhang, H., Xue, M., & Liang, H. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c06337 · Cited by 20
Leukotriene signaling in neurodegeneration: implications for treatment strategies
Sharma, V., Sharma, P., & Singh, T. G. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01557-1 · Cited by 22
“Neuroinflammation and NDDs have been linked to the disruption of Cys-LT signaling in the brain.”
InfluentialChen, L.-X., Zhang, M.-D., Xu, H., Ye, H.-Q., Chen, D.-F., Wang, P., Bao, Z.-W., Zou, S.-M., Lv, Y.-T., Wu, Z., et al. (2024) · Research · doi:10.34133/research.0548 · Cited by 29
Mittal, R., Ocak, E., Zhu, A., Perdomo, M. M., Peña, S., Mittal, J., Bohorquez, J. E., & Eshraghi, A. A. (2019) · The Anatomical Record · doi:10.1002/ar.24065 · Cited by 22
“This immunomodulatory effect is particularly important as inflammation plays a significant role in neurodegenerative diseases including those of the central auditory pathways (Chen et al., 2016; Ransohoff, 2016).”
BackgroundAftabizadeh, M., Tatarek‐Nossol, M., Andreetto, E., Bounkari, O. E., Kipp, M., Beyer, C., Latz, E., Bernhagen, J., & Kapurniotu, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00260 · Cited by 22
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults
Halaas, N. B., Henjum, K., Blennow, K., Dakhil, S., Idland, A., Nilsson, L. N. G., Sederevičius, D., Dídac Vidal-piñeiro, A., Walhovd, K. B., Wyller, T. B., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz240 · Cited by 21
Zhao, J., Xu, C., Cao, H., Zhang, L., Wang, X., & Chen, S. (2019) · PeerJ · doi:10.7717/peerj.8324 · Cited by 20
Immune Regulation of Adult Neurogenic Niches in Health and Disease
Chintamen, S., Imessadouene, F., & Kernie, S. G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.571071 · Cited by 25
miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology
Walsh, A. D., Nguyen, L., & Binder, M. D. (2021) · ASN NEURO · doi:10.1177/1759091420981182 · Cited by 23
“This paradigm of “good” and “bad” microglia is not black and white, microglial activation is multi-faceted whereby these cells can adopt many phenotypes with significant overlaps in gene expression (Ransohoff, 2016b).”
BackgroundHuman iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development
Heider, J., Vogel, S., Volkmer, H., & Breitmeyer, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910254 · Cited by 26
“Detrimental effects of uncontrolled inflammation are suggested to contribute to the onset and development of several neuropsychiatric or neurodegenerative diseases [22].”
BackgroundArredondo, S. B., Reyes, D. T., Herrera-Soto, A., Mardones, M. D., Inestrosa, N. C., & Varela‐Nallar, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-01977-x · Cited by 22
Streyczek, J., Apweiler, M., Sun, L., & Fiebich, B. L. (2022) · Molecules · doi:10.3390/molecules27030784 · Cited by 23
“Responding to various pathological situations by phagocytosis and tissue repair, they ensure the protection of the brain’s parenchyma [18].”
BackgroundWelcome, M. O. (2018) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000492491 · Cited by 22
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Balkhi, S., Spirito, A. D., Poggi, A. D., & Mortara, L. (2025) · Cells · doi:10.3390/cells14040264 · Cited by 23
“In the context of AD, microglia recognize A β and phosphorylated tau proteins as damage-associated molecular patterns through receptors like TLR-4 [171].”
Wang, Y., Liu, J., Li, P., Peng, Z., Zhang, Y., Liu, Y., Li, M., Gong, X., Liu, D., Xu, E., et al. (2025) · Advanced Science · doi:10.1002/advs.202504486 · Cited by 26
Pradhan, L. K., & Das, S. K. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00893-4 · Cited by 22
Schmal, Z., Hammer, B., Müller, A., & Rübe, C. E. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.07.007 · Cited by 21
Lombardi, G., Paganelli, R., Abate, M., Ireland, A., Molino-Lova, R., Sorbi, S., Macchi, C., Pellegrino, R., Iorio, A. D., & Cecchi, F. (2021) · GeroScience · doi:10.1007/s11357-021-00474-3 · Cited by 22
Neshan, M., Malakouti, S. K., Kamalzadeh, L., Makvand, M., Campbell, A., & Ahangari, G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210480 · Cited by 21
Bi-Directional Relationship Between Autophagy and Inflammasomes in Neurodegenerative Disorders
Panda, C., & Mahapatra, R. K. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01184-2 · Cited by 23
“The role of neuroinflammation is now well evident in the neurodegeneration of the aging brain (Ransohoff 2016).”
BackgroundOkuda, S., Uemura, N., Sawamura, M., Taguchi, T., Ikuno, M., Uemura, M. T., Yamakado, H., & Takahashi, R. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01169-5 · Cited by 19
“In the present study, microglial activation shown by hypertrophic change [50, 51] and an increase in the number were observed before obvious dopaminergic neuron loss in the mPFF-injected A53T BAC-SNCA Tg mice, suggesting that microglia may play some roles in the degenerative processes in this model.”
BackgroundKang, R., Gamdzyk, M., Luo, Y., Tang, H. C., Huang, L., Lenahan, C., Doycheva, D. M., Li, D., Tang, J., Tan, S., et al. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01032-5 · Cited by 21
“Accumulating evidence suggests that neurological disorders occur in part because the environment is affected during disease in a cascade of processes collectively named neuroinflammation [32].”
BackgroundKim, J., Jeon, S. G., Jeong, H.-R., Park, H., Kim, J., & Hoe, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113606 · Cited by 22
Chen, L., Wang, N., Zhang, Y. N., Li, D., He, C., Li, Z., Zhang, J., & Guo, Y. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104776 · Cited by 22
Wang, Y.-X., Xu, Z., Qin, S.-Y., Du, N., Yao, G., Lin, B., Huang, X., & Song, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06733 · Cited by 20
Li, H., Wei, J., Zhang, Z., Li, J., Ma, Y., Zhang, P., & Lin, J. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03330-7 · Cited by 20
Ye, L., Shu, S., Jia, J., Sun, M., Xu, S., Bao, X., Bian, H., Liu, Y., Zhang, M., Zhu, X., et al. (2023) · Aging Cell · doi:10.1111/acel.13860 · Cited by 20
“Among these, neuroinflammation during aging inevitably affects the functional properties of microglia, and altered microglial function is also a hallmark of brain aging (Brawek et al., 2021; Ransohoff, 2016).”
BackgroundMa, Y., Shi, Q., Xiao, K., Wang, J., Chen, C., Gao, L., Gao, C., & Dong, X. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00354 · Cited by 20
Ala, M., Jafari, R. M., Hajiabbasi, A., & Dehpour, A. R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30318 · Cited by 20
“Herein, neuroinflammation is known as one of the most com- plicated types of inflammation which precedes many neurodegen- erative diseases, such as Alzheimer's and Parkinson's diseases (Ransohoff, 2016).”
BackgroundEffect of memantine, an anti-Alzheimer’s drug, on rodent microglial cells in vitro
Murakawa‐Hirachi, T., Mizoguchi, Y., Ohgidani, M., Haraguchi, Y., & Monji, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-85625-4 · Cited by 20
Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
Grossmann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094805 · Cited by 20
Hu, H., Wan, S., Hu, Y., Wang, Q., Li, H., & Zhang, N. (2025) · Annals of Medicine · doi:10.1080/07853890.2024.2445194 · Cited by 21
“Neuroinflammation is a chronic inflammatory phenomenon within the CNS that is characterized by the production of a large amount of proinflammatory factors by activated microglia and astrocytes [47].”
Zhang, Z., Niu, K., Huang, T., Guo, J., Xarbat, G., Gong, X., Gao, Y., Liu, F., Shan, C., Su, W., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-024-00846-4 · Cited by 29
Zou, Y., Zhang, J., Chen, L., Xu, Q., Yao, S., & Chen, H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030388 · Cited by 23
The metabolic engine of cognition: microglia–neuron interactions in health, ageing and disease
Asimakidou, E., Pluchino, S., Silva, B. A., & Peruzzotti‐Jametti, L. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01409-4 · Cited by 28
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 21
Pons-Espinal, M., Blasco-Agell, L., & Consiglio, A. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03700-x · Cited by 18
Alterations in Chromatin Structure and Function in the Microglia
Fujita, Y., & Yamashita, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.626541 · Cited by 23
“Microglia respond rapidly to pathological stimuli via changes in morphology and function, such as releasing inflammatory cytokines, increased proliferation, and exhibiting active phagocytic properties (Ransohoff and Perry, 2009; Kettenmann et al., 2011; Shemer et al., 2015; Ransohoff, 2016).”
BackgroundTung, M., Fung, K.-M., Hsu, H.-M., & Tseng, T. (2021) · RSC Advances · doi:10.1039/d1ra05311f · Cited by 20
Obenaus, A., Rodriguez‐Grande, B., Lee, J. B., Dubois, C., Fournier, M., Cador, M., Caillé, S., & Badaut, J. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01515-y · Cited by 22
Song, X., Wang, Z., Tian, Z., Wu, M., Zhou, Y., & Zhang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076399 · Cited by 19
Zhu, M., Zhang, J., Guo, L., Yue, R.-Z., Li, S.-S., Cui, B.-Y., Guo, S., Niu, Q., Yu, Y., Wang, H.-H., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175874 · Cited by 21
Liu, W., Zhang, Y.-R., Ge, Y., Wang, H.-F., Cheng, W., & Yu, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03648-6 · Cited by 21
“Genetics are important in identifying the putative relationships among inflammation, brain structures, and neuro-degenerative disorders [13].”
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105724 · Cited by 21
“Neuroinflammation plays a key role in various neurodegenerative diseases (Ransohoff, 2016; Leng and Edison, 2021; Lempriere, 2023) and by enhancing glial pro-inflammatory activity and exacerbating aberrant neuronal signalling through deleterious neuroinflammatory responses, aging might deteriorate…”
BackgroundNeuromodulatory effects of leukotriene receptor antagonists: A comprehensive review
Sood, R., Anoopkumar‐Dukie, S., Rudrawar, S., & Hall, S. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176755 · Cited by 20
Liu, X., Xiu, C., Zhao, N., Geng, F., Zhu, M., & Ren, Q. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13704 · Cited by 21
Jiang, X., Ganesan, P., Rengarajan, T., Choi, D., & Arulselvan, P. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.162 · Cited by 19
Pathophysiological Role of TRPM2 in Age-Related Cognitive Impairment in Mice
Kakae, M., Miyanohara, J., Morishima, M., Nagayasu, K., Mori, Y., Shirakawa, H., & Kaneko, S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.012 · Cited by 20
“Studies show that dystrophic changes occur in the aged human brain 4 (Ransohoff, 2016).”
BackgroundGlia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
Ban, J., Sámano, C., Mladinić, M., & Munitić, I. (2019) · Croatian Medical Journal · doi:10.3325/cmj.2019.60.109 · Cited by 23
Fu, S.-Y., Xiong, R., Peng, Y., Zhang, Z.-H., Chen, X., Zhao, Y., Ning, Y., Yang, N., Zhou, Y., & Li, P. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02895-1 · Cited by 20
Hernandez, S. J., Fote, G., Reyes-Ortiz, A. M., Steffan, J. S., & Thompson, L. M. (2021) · Matrix Biology Plus · doi:10.1016/j.mbplus.2021.100089 · Cited by 17
“While aggregate phagocytosis by astrocytes in neurodegenerative disease initially aids in facilitating clearance of misfolded proteins released by neurons [46,47], the eventual inability to clear this toxic buildup in later disease stages leads to proteotoxic neurodegeneration through cytokine and chemokine release in…”
BackgroundYoshino, Y., Ozaki, Y., Yamazaki, K., Sao, T., Mori, Y., Ochi, S., Iga, J., & Ueno, S. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00275 · Cited by 16
“TREM2, which is expressed at high levels in microglia (Owens et al., 2017), plays a role in neurodegenerative diseases (Ransohoff, 2016).”
BackgroundLei, Y., Huang, Y., Wang, Y., & He, X. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.09.022 · Cited by 18
Emerging roles of leptin in Parkinson’s disease: Chronic inflammation, neuroprotection and more?
Regensburger, M., Rasul Chaudhry, S., Yasin, H., Zhao, Y., Stadlbauer, A., Buchfelder, M., & Kinfe, T. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.09.010 · Cited by 17
Chen, J., Pan, Y., Liu, Q., Li, G., Chen, G., Li, W., Zhao, W., & Wang, Q. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221115150253 · Cited by 19
A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration
Grandke, F., Fehlmann, T., Kern, F., Gate, D., Wolff, T. W., Leventhal, O., Channappa, D., Hirsch, P., Wilson, E. N., Meese, E. U., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56833-7 · Cited by 21
Hu, Y., Zhang, P., & Wang, X. (2025) · Physiological Research · doi:10.33549/physiolres.935410 · Cited by 21
“Accumulating documents have pointed out that the activation of microglia is heterogeneous, including classic pro-inflammatory M1 phenotype and anti-inflammatory M2 phenotype [5].”
Miao, G., Fortier, T. M., Liu, H., Schafer, D. P., Fitzgerald, K. A., Mao, J., & Baehrecke, E. H. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01602-9 · Cited by 21
“Dysfunctional mitochondria and inflammation are associated with diseases, and increasing evidence indicates that inflammation in the brain contributes to neurodegenerative disorders and could be a target for therapies 1 .”
Han, C., Wang, H., Zhang, M., Wu, L., Wang, A., Yang, P., Gao, Y., Zhang, C., Gao, J., Xue, T., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03517-0 · Cited by 25
“…exposure factors, which may involve changes in the protein homeostasis of α-synuclein (α-Syn), mitochondrial function, oxidative stress, calcium homeostasis, autophagy deficiency, axonal transport, and neuroinflammation, have been found to promote the pathological progression of PD [2, 3].”
Almalki, W. H., Alghamdi, S. A., Alzahrani, A., & Zhang, W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.018 · Cited by 17
Wang, W., Wang, J., Tang, Q., Zhu, X., Zhu, R., Cui, D., Wei, C., Liu, X., Liu, X., Ran, S., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.053 · Cited by 17
Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
García-García, R., Martín-Herrero, L., Blanca-Pariente, L., Pérez-Cabello, J. A., & Roodveldt, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413280 · Cited by 18
“Apart from these general cytotoxic mechanisms, neuroinflammation—a non-cell autonomous mechanism of neurodegeneration and neuronal loss—is currently considered a key player in the onset and progression of ALS and other neurodegenerative diseases [7].”
Mendiola, A. S., Church, K. A., Cardona, S. M., Vanegas, D., Garcia, S. A., Macklin, W. B., Lira, S. A., Ransohoff, R. M., Kokovay, E., Lin, C. A., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15616 · Cited by 17
Self-citationA new alkaloid and two organic acids from Portulaca oleracea L. and their bioactivities
Liu, P., Lan, X., Tao, X., Tian, J., Ying, X., & Stien, D. (2022) · Natural Product Research · doi:10.1080/14786419.2022.2103696 · Cited by 18
“…can further trigger the inflammatory response mediated by microglia and astrocytes (Lee et al. 2008), releasing large amounts of inflammatory factors, such as IL-1 β , TNF-α , which promote neuronal apoptosis and ultimately lead to the nervous system disorders (Ransohoff 2016; Dong et al. 2019).”
Schmal, Z., & Rübe, C. E. (2022) · Cancers · doi:10.3390/cancers14225477 · Cited by 21
“Higher numbers of stem and progenitor cells in the developing brain enhance this inherent vulnerability to ionizing radiation, and the pronounced neuronal damage explains the enhanced inflammatory reaction in the premature hippocampus [16].”
BackgroundStem cells in the treatment of Alzheimer's disease – Promises and pitfalls
Bhatti, J. S., Khullar, N., Mishra, J., Kaur, S., Sehrawat, A., Sharma, E., Bhatti, G. K., Selman, A., & Reddy, P. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166712 · Cited by 22
Role of the Voltage-Gated Proton Channel Hv1 in Nervous Systems
Shen, Y., Luo, Y., Liao, P. S., Zuo, Y., & Jiang, R. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01053-6 · Cited by 22
“Because of the evidence that microglia are highly involved in neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis [133, 134], it would not be surprising if Hv1 played a role in these diseases.”
BackgroundWang, L., Bai, Y., Tao, Y., Wei, S. H. E. N., Zhou, H., He, Y., Wu, H. B. K., Huang, F., Shi, H., & Xiaojun, W. U. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60449-2 · Cited by 20
“TGR5 is the only known G-protein receptor that responds to bile acid by producing cAMP ([40]).”
BackgroundWatanabe, H., Shima, S., Kawabata, K., Mizutani, Y., Ueda, A., & Ito, M. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1507033 · Cited by 27
Ethical Implications of the Mild Encephalitis Hypothesis of Schizophrenia
Riedmüller, R., & Müller, S. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00038 · Cited by 18
“Furthermore, neuroinflammation potentially contributes to neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia (56).”
BackgroundOgunrinade, F., Guetchueng, S. T., Katola, F. O., Aderogba, M. A., Akande, I., Sarker, S. D., & Olajide, O. A. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa019 · Cited by 20
The etiopathogenetic and pathophysiological spectrum of parkinsonism
Bologna, M., Truong, D. D., & Jankovic, J. J. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120012 · Cited by 21
Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
Nobili, P., Shen, W., Milicevic, K. D., Pristov, J. B., Audinat, É., & Nikolic, L. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.900337 · Cited by 21
“It is characterized by the recruitment of immune cells to the CNS and also by a transformation of astrocytes and microglia into reactive profiles (Ransohoff, 2016; Yang and Zhou, 2019).”
BackgroundSampaio, T. B., Sari, M. H. M., Pesarico, A. P., Mantovani, A. C., Zeni, G. R., & Nogueira, C. W. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.001 · Cited by 17
“Neuroinflammation is a characteristic feature of PD pathology and evidence has been found to suggest that inflammatory process has a crucial role in neurodegeneration (Ransohoff, 2016).”
BackgroundInfluentialSpecks of insight into Alzheimer’s disease
Ransohoff, R. M. (2017) · Nature · doi:10.1038/d41586-017-08668-6 · Cited by 20
Self-citationCrabbé, M., der Perren, A. V., Kounelis-Wuillaume, S., Lavreys, T., Bormans, G. M., Baekelandt, V., Casteels, C., & Laere, K. V. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.112964 · Cited by 18
A Pivotal Role of the Nrf2 Signaling Pathway in Spinal Cord Injury: A Prospective Therapeutics Study
Samarghandian, S., Pourbagher‐Shahri, A. M., Ashrafizadeh, M., Khan, H. Z., Forouzanfar, F., Aramjoo, H., & Farkhondeh, T. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200604175118 · Cited by 19
Yang, S., Tian, M., Dai, Y., Feng, S., Wang, Y., Chhangani, D., Ou, T., Li, W., Yang, Z. H., McAdow, J. F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.20.423533 · Cited by 17
“number of factors, the inflammatory pathways appear to converge on a common disease 22 mechanism that initiates neurodegeneration, defined as the disruption of neural function 23 through changes in neuronal structure or survivability (Glass et al., 2010; Ransohoff, 2016).”
MicroRNAs Modulating Neuroinflammation in Parkinson's disease
Saadh, M. J., Muhammad, F. A., Singh, A., Mustafa, M. A., Zuhairi, R. A. H. A., Ghildiyal, P., Hashim, G. M., Alsaikhan, F., Khalilollah, S., & Akhavan‐Sigari, R. (2024) · Inflammation · doi:10.1007/s10753-024-02125-z · Cited by 16
“The toxic role of activated microglia has been investigated in PD models, and it found that toxic activated microglia dominate in PD and play a critical role in PD development by degrading DA [43].”
TREM2 in neurodegeneration and diseases
Abdulkhaliq, A. A., Alasiri, G., Kim, B., Khan, J., Ajoolabady, A., Yousof, S. M., Ren, J., Tuomilehto, J., Borai, A., Alrfaei, B. M., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03505-7 · Cited by 16
Elevated 4R‐tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation
Setó‐Salvia, N., Esteras, N., de Silva, R., Pablo‐Fernández, E. D., Arber, C., Toomey, C. E., Polke, J. M., Morris, H. R., Rohrer, J. D., Abramov, A. Y., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17136 · Cited by 12
Genetics of COVID ‐19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review
Tziastoudi, M., Cholevas, C., Stefanidis, I., & Theoharides, T. C. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51631 · Cited by 22
Micheli, L., Lucarini, E., Nobili, S., Bartolucci, G., Pallecchi, M., Toti, A., Ferrara, V., Ciampi, C., Ghelardini, C., & Mannelli, L. D. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221128091453 · Cited by 18
Xia, X., Li, H., Xu, X., Wu, C., Wang, Z., Yi, J., Zhao, G., & Du, M. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213419 · Cited by 16
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.